Lexapro Birth Defects

Multiple studies have found that children born to women who use Lexapro while pregnant face an increased risk of developing congenital heart defects or other birth defects.

The Food and Drug Administration issued a warning in 2006 stating that women who use SSRIs such as Lexapro are up to six times more likely to give birth to a child with primary pulmonary hypertension of the newborn (PPHN) than women using other antidepressants. PPHN is a serious circulatory condition that can potentially be fatal.

In 2007, two studies published by the New England Journal of Medicine found that the children of women who used Lexapro or other SSRI antidepressants while pregnant may be twice as likely to suffer from congenital birth defects. These birth defects included anencephaly, omphalocele and craniosynostosis.

Children born to women who used Lexapro while pregnant may also be at increased risk for other birth defects, including:

• Anal Atresia

• Atrial Septal Defects

• Cleft lip

• Cleft Palate

• Club Foot

• Pulmonary Stenosis

• Spina Bifida

• Tetralogy of the Fallot

• Ventricular Septal Defects (VSD)

If you or a loved one took the antidepressant Lexapro during pregnancy and gave birth to a child with PPHN, craniosynostosis or other birth defects, contact the lawyers at Hissey Kientz, LLP for a free case evaluation. You can reach us by calling toll-free at 1-866-275-4454, or by filling out our free contact form on the right of this page.

I am currently represented by an attorney
*Required fields